SOLAL
Homocysteine Lowering Formula
Homocysteine Lowering Formula
Nappi code: 704934-001
Low stock: 3 left
- Professional grade products recommended by healthcare practitioners, delivered directly to your door.
Couldn't load pickup availability
PRODUCT DESCRIPTION
Homocysteine Lowering Formula by SOLAL® contains a combination of vitamins, folate, inositol and zinc important in the methylation cycle. The methylation cycle in cells is responsible for converting homocysteine to methionine. High levels of homocysteine is associated with increased risk of neurological and heart disease.
RECOMMENDED USAGE
Adults: Take one capsule daily with food.
COMPOSITION
| Serving size : 1 capsule | Amount per serving |
| Inositol | 242,5 mg |
| Zinc amino acid chelate | 100,0 mg |
| providing zinc | 20,0 mg |
| Pyridoxal-5-phosphate (vitamin B6) | 68,5 mg |
| Riboflavin-5-phosphate (vitamin B2) | 13,3 mg |
| L-5-methyltetrahydrofolate calcium | 543,0 mcg |
| providing folate | 500,0 mcg |
| Methylcobalamin (vitamin B12) | 98,5 mcg |
OTHER INGREDIENTS
Magnesium stearate, microcrystalline cellulose and talc
Contains sugar: Inositol 0,25 g/tablet
DOES NOT CONTAIN
Suitable for vegans and vegetarians
STORAGE
Store in a cool dry place (<25°C), away from sunlight. Keep out of reach of children.
PRODUCT FORM
Capsule
WARNINGS/CONTRAINDICATION
If pregnant, nursing or taking medication, consult your healthcare practitioner before use.
Do not use this product if you have an allergy or sensitivity to any of the ingredients.
If you are on any medication or suffering from any medical condition, it is advisable to seek medical advice before starting any new medicine, supplement or remedy.
Do not exceed recommended dosage(s) unless on the advice of a healthcare practitioner.
Carbamazepine, lithium and valproic acid reduce the level of inositol in the brain by inhibiting enzymes responsible for inositol production in the brain.
The effect on brain inositol levels may contribute to their effect on bipolar disorder.
The effect of inositol supplementation on their therapeutic effect in bipolar disease is unknown.
Please review package insert (if available) for further information.